Flu Pamphlet Impacts Parents’ Decision to Vaccinate Kids
A new study by researchers at Columbia University has found handing a pamphlet about influenza (flu) to parents in pediatricians’ waiting rooms can have a significant impact on increasing the uptake of the flu vaccine.
HHS Grants Additional Money to Expand Access to Effective Opioid Treatment
The U.S. Department of Health and Human Services released an additional $487 million to supplement first-year funding through its State Opioid Response grant program.
FDA Seeks to Enhance Clinical Trial Diversity with New Guidance
The U.S. Food and Drug Administration has issued draft guidance to overcome obstacles to increasing enrollment diversity in clinical trials.
New CMMI Direct-Contracting Pay Models Will Overhaul Fee-for-Service Models
The Centers for Medicare and Medicaid Innovation is introducing new pay models that will shift primary care from fee-for-service payments to a global fee model under which clinicians and hospitals could assume varying amounts of risk.
SCIG with Recombinant Human Hyaluronidase Is Safe and Preferred vs IVIG by Some Multifocal Motor Neuropathy Patients
A team of Dutch investigators enrolled 18 multifocal motor neuropathy (MMN) patients on intravenous immune globulin(IVIG) treatment in a prospective open-label study to evaluate the comparative safety of treatment with 10% human immune globulin whose subcutaneous administration is facilitated with recombinant human hyaluronidase (fSCIG) (HyQvia).
Patients on IVIG Therapy for Neurological Disorders Successfully Transitioned to SCIG Therapy
Canadian investigators at Ottawa Hospital have reported a very high success rate with a nurse-led individualized program to facilitate a smooth transition in patients with neurological disorders from chronic intravenous immune globulin (IVIG) to subcutaneous immune globulin (SCIG) treatment.
Scientists Uncover Breakthrough in Development of Universal Flu Vaccine
Researchers at the University of Melbourne have discovered immune cells that can fight all different kinds of the influenza (flu) virus.
Excellent Response to Therapeutic Plasma Exchange in Myasthenia Gravis Patients with or Without Autoantibodies
A study out of the University of Texas Southwestern Medical Center found a 96 percent response rate to treatment with therapeutic plasma exchange (PLEX) in a series of 58 consecutive myasthenia gravis (MG) patients, with no significant difference in response between those with or without autoantibodies.
CMS Launches Artificial Intelligence Health Outcomes Challenge
CMS has launched the Artificial Intelligence Health Outcomes Challenge, a three-stage competition to accelerate artificial intelligence solutions that will potentially be used by CMS’s Innovation Center.
FDA Implements Added Efforts to Tackle e-Cigarette Use and Addiction by Kids
The FDA is making efforts as part of its Youth Tobacco Prevention Plan to ensure no tobacco products are marketed to, sold to or used by kids.
